does semaglutide make you emotional and Anxiety: What Need to Know Discover the Surprising Mental Health

If hair preservation is a top priority and the primary goal is moderate weight management rather than substantial loss, these older compounds might warrant discussion with a prescriber

4 Current therapeutic landscape and unmet need While resmetirom (a THR- agonist) has recently gained FDA approval for the treatment of MASH (in patients with fibrosis F2-F3), marking the first-ever pharmacological agent for this condition (Liu et al., 2025), there remains no single FDA-approved drug that effectively prevents or reverses the progression of advanced SLD to HCC

Summary Though alpha-lipoic acid has properties that may promote weight loss, its overall effect in humans seems negligible

Long-term observational trials of Epithalamin have reported associations with improved survival and cardiovascular markers in elderly populations with extended follow-up

Deep sleep can rewire the anxious brain

How might a GLP-1 receptor agonist add to this risk picture